Chemical Structure (Argatroban 1)
Argatroban Injection
Product Images NDC 42023-182
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Argatroban (NDC 42023-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Argatroban 2)
Figure2 (Argatroban 3)
Figure 3 (Argatroban 4)
This text provides information about a study comparing argatroban with a historical control group. Argatroban group (N=160) had 119 censored data, while the historical control group (N=147) had 90 censored data. The p-value was calculated as 0.007. The study day information is also present.*
Figure 4 (Argatroban 5)
This Is An Image Of The Argatroban Injection Carton, 250 mg/2.5 mL (100 mg/ml), Premier Pro Rx. (Argatroban 6)
This text is a medication label for an Argatroban injection. It contains information about the contents of the injection, such as Argatroban 250 mg, D-sorbitol 750 mg, and Dehydrated Alcohol 1000 mg. The label also includes instructions for use, storage conditions, and a precaution not to freeze the product. It advises to dilute the solution prior to use and to protect it from light. Additionally, there is a note about not using the solution if it appears cloudy. The medication is intended for intravenous use only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
